The PERFUSE study: the experience of patients receiving Adalimumab biosimilar SB5
Bouhnik Y, Carbonnel F, Fumery M, Flamant M, Buisson A, Camoin A, et al. Research article in Digestive and Liver Disease (Juin 2023)....
The PERFUSE study: the experience of patients receiving Adalimumab biosimilar SB5
Real-world evidence of the use of the infliximab biosimilar SB2: data from the PERFUSE study
PERFUSE: a French non-interventional study of patients with inflammatory bowel disease [...]
PERFUSE - Étude observationnelle française de patients atteints de rhumatisme inflammatoire [...]
PERFUSE : Étude de cohorte française non interventionnelle de patients naïfs et en transition [...]
PERFUSE : étude de cohorte française non-interventionnelle de patients naïfs ou en transition [...]
PERFUSE : étude non-interventionnelle d’une cohorte de patients naïfs d’infliximab et [...]